Investors to Bush: We Like hESC
While the current president is reiterating his opposition to human embryonic stem cell research, investors are beginning to look to the future.
We have reported previously that the prospect of a favorable presidential change has eased some of the fears of stem cell investors. One further sign is the announcement today that UBS Investment Research upgrad…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.